European shares finished marginally higher on Monday, supported by defence stocks, while Novo Nordisk gained after data showed its weight-loss drug Wegovy delivers stronger heart-protective benefits than Eli Lilly's rival therapies.
The pan-European STOXX 600 closed up 0.17% at 551.07, with gains led by the aerospace and defence index, which surged 2.1% to hover near a record high.
Defence giants, Rolls-Royce Holdings, Rheinmetall and Hensoldt advanced between 2.8% and 4.5%.
Gains followed a Financial Times report that European Commission President Ursula von der Leyen said Europe was preparing "pretty precise plans" to send troops to Ukraine as part of post-conflict security guarantees.
Britain's BAE Systems was up 1.8%, as Norway said it had chosen Britain for the acquisition of new frigates, in a deal worth some 10 billion pounds ($13.51 billion).
Danish drugmaker Novo Nordisk, the fourth-largest healthcare company on the STOXX index, rose 1.8% after the company said Wegovy cut the risk of heart attack, stroke or death by 57% versus Eli Lilly's rival medicines Mounjaro and Zepbound in a real-world comparison.
The stock bolstered the healthcare index, rising 0.27%. Denmark's main stock index gained 1.1%, also aided by Novo's domestic peer Zealand Pharma that ended 3.5% higher.
Overall gains were limited by a jump in long-dated euro zone bond yields on persistent worries about government debt levels around the world.
Source : Reuters
European shares closed higher on Thursday after a series of lukewarm sessions, as investors welcomed the U.S. Federal Reserve's overnight interest rate cut and assessed a policy decision from the Swis...
Both the STOXX 50 and the STOXX 600 slipped 0.2% on Thursday, marking a third straight session of losses for the former. Weak sales and profit forecasts from Oracle weighed on the tech sector, oversh...
Asia-Pacific markets opened higher on Thursday morning after the Federal Reserve delivered its third interest rate cut this year. The Fed cut the Fed Funds Rate by 25 bps to a range of 3.5%–3.75% and ...
European equities edged lower on Wednesday as investors adopted a cautious stance ahead of the Federal Reserve's policy decision, limiting risk taking across regional markets. The STOXX 50 fell 0.3%,...
European shares inched lower on Wednesday, as investors refrained from placing big bets ahead of the U.S. Federal Reserve's interest rate decision, while also parsing through a slate of corporate upda...
European shares closed higher on Thursday after a series of lukewarm sessions, as investors welcomed the U.S. Federal Reserve's overnight interest rate cut and assessed a policy decision from the Swiss National Bank. The pan-European STOXX 600...
Silver climbed above $61 per ounce, extending a record rally as markets digested the Fed's 25 basis point cut and parsed Chair Powell's remarks which markets read as relatively dovish even as committee guidance remained cautious. The cut itself...
Gold prices surged tonight due to a combination of dovish sentiment from the Fed and market concerns about the future economic outlook. Following the interest rate cut and signals that the Fed is no longer aggressive about raising interest rates,...
The Job Openings and Labor Turnover Survey (JOLTS) will be released on Tuesday by the U.S. Bureau of Labor Statistics. Due to the prolonged...
The latest survey data from the US Bureau of Labor Statistics has reported an increase in JOLTs Job Openings, a key indicator of the health of the...
European stocks edged higher on Tuesday (December 9th) as global investors awaited the US Federal Reserve's monetary policy update.
The...
White House economic adviser Kevin Hassett said Tuesday there is "plenty of room" to cut interest rates further, though he noted that rising...